| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Division of Oncology, Department of Medicine, and the
Division of Immunology and Transplantation Biology, Department of Pediatrics, Stanford University Medical Center, Stanford, CA 94305
Vaccination with naked DNA encoding a specific allergen has been
shown previously to prevent, but not reverse, the development of
allergen-induced airway hyperresponsiveness (AHR). To enhance the
effectiveness of DNA vaccine therapies and make possible the treatment
of established AHR, we developed a DNA vaccination plasmid containing
OVA cDNA fused to IL-18 cDNA. Vaccination of naive mice either with
this fusion DNA construct or with an OVA cDNA-containing plasmid
protected the mice from the subsequent induction of AHR. Protection
from AHR correlated with increased IFN-
production and reduced
OVA-specific IgE production. The protection appeared to be mediated by
IFN- and CD8+ cells because treatment of mice with
neutralizing anti-IFN- mAb or with depleting anti-CD8 mAb
abolished the protective effect. Moreover, vaccination of mice with
preexisting AHR with the OVA-IL-18 fusion DNA, but not with the OVA
cDNA plasmid, reversed established AHR, reduced allergen-specific IL-4,
and increased allergen-specific IFN- production. Thus, combining
IL-18 cDNA with OVA cDNA resulted in a vaccine construct that protected
against the development of AHR, and that was unique among cDNA
constructs in its capacity to reverse established
AHR.
This article has been cited by other articles:
|
|
 |
|
  H. Jin, Y. Kang, L. Zhao, C. Xiao, Y. Hu, R. She, Y. Yu, X. Du, G. Zhao, T. Ng, et al. Induction of Adaptive T Regulatory Cells That Suppress the Allergic Response by Coimmunization of DNA and Protein Vaccines J. Immunol., April 15, 2008; 180(8): 5360 - 5372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zindler, N. Gehrke, C. Luft, S. Reuter, C. Taube, S. Finotto, A. B. Reske-Kunz, and S. Sudowe Divergent Effects of Biolistic Gene Transfer in a Mouse Model of Allergic Airway Inflammation Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 38 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Salagianni, W. K. Loon, M. J. Thomas, A. Noble, and D. M. Kemeny An Essential Role for IL-18 in CD8 T Cell-Mediated Suppression of IgE Responses J. Immunol., April 15, 2007; 178(8): 4771 - 4778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A Dinarello Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process Am. J. Clinical Nutrition, February 1, 2006; 83(2): 447S - 455S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang-Hoover, P. Finn, and J. Stein-Streilein Modulation of Ovalbumin-Induced Airway Inflammation and Hyperreactivity by Tolerogenic APC J. Immunol., December 1, 2005; 175(11): 7117 - 7124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Taube, J. A. Nick, B. Siegmund, C. Duez, K. Takeda, Y.-H. Rha, J.-W. Park, A. Joetham, K. Poch, A. Dakhama, et al. Inhibition of Early Airway Neutrophilia Does Not Affect Development of Airway Hyperresponsiveness Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 837 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Ford, D. Rennick, D. D. Donaldson, R. Venkayya, C. McArthur, E. Hansell, V. P. Kurup, M. Warnock, and G. Grunig IL-13 and IFN-{gamma}: Interactions in Lung Inflammation J. Immunol., August 1, 2001; 167(3): 1769 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Woodruff and J. V. Fahy Asthma: Prevalence, Pathogenesis, and Prospects for Novel Therapies JAMA, July 25, 2001; 286(4): 395 - 398. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
